Prior oral contraceptive use is associated with higher blood pressure in older women

Journal of Women's Health

Volumn 7, Issue 2, 1998, Pages 221-228

  Brady, Wanda A ^a   Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a   Morales, Arlene J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LIPOPROTEIN; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART DISEASE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031966649     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.221     Document Type: Article

References (31)

1. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med 1981;305:420.
2. Stampfer MJ, Willet WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of the past use of oral contraceptive agents and the risk of cardiovascular diseases. N Engl J Med 1988;319:1313.
3. Royal College of General Practitioner's Oral Contraception Study. Further analysis of mortality in oral contraceptive users. Lancet 1981;1:541.
4. Mann JI, Inman WHW. Oral contraceptives and death from myocardial infarction. Br. Med J 1975;2:245.
5. Mann JI, Vessey MP, Thorogood M, Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J 1975;2:241.
6. Mann JI, Inman WHW, Thorogood M. Oral contraceptive use in older women and fatal myocardial infarction. Br Med J 1976;2:445.
7. Shapiro S, Sloane D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS. Oral contraceptive use in relation to myocardial infarction. Lancet 1979;1:743.
8. Petitti DB, Wingerd J, Pelligren F, Ramcharan S. Risk of vascular disease in women: Smoking, oral contraceptives, noncontraceptive estrogens, and other fac-tors. JAMA 1979;242:1150.
9. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol 1980;111:59.
10. Beral V, Layade PM. Further analysis of mortality in oral contraceptive users. Lancet 1981;1:541.
11. Leaf DA, Bland D, Shlaad D, Neighbor WE, Scott CS. Oral contraceptive use and coronary risk factors in women. Am J Med Sci 1991;301:365.
12. Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Milson E. Blood pressure in women taking oral contraceptives. Br Med J 1974;1:533.
13. Perlman JA, Russell-Briefel R, Ezzati T, Lieberknecht G. Oral glucose tolerance and the potency of contraceptive progestins. J Chronic Dis 1985;38:857.
14. Phillips N, Duffy T. One-hour glucose tolerance in relation to the use of contraceptive drugs. Am J Obstet Gynecol 1973;116:91.
15. Gaspard U. Metabolic effects of oral contraceptives. Am J Obstet Gynecol 1987;157:1029.
16. Fisch IR, Frank S. Oral contraceptives and blood pressure. JAMA 1997;237:2499.
17. Wynn V, Mills GL, Doar JWH, Stokes T. Fasting serum triglycerides, cholesterol, and lipoprotein levels during oral contraceptive therapy. Lancet 1969;2: 756.
18. Heiss G, Tamir I, David CE, Hulley SB. Lipoprotein-cholesterol distributions in selected N.A. populations, LRCPPS. Circulation 1980;61:302.
19. Hennekens CH, Evans DA, Castelli WP. Oral contraceptive use and fasting triglycerides, plasma cholesterol and HDL cholesterol. Circulation 1979;60:486.
20. Knopp RH, Walden CE, Wahl PW, Hoover JJ. Oral contraceptives and postmenopausal estrogen effect on lipoprotein, triglycerides, and cholesterol in an adult female population: Relationships to estrogen and progestin potency. J Clin Endocrinol 1981;53: 1123.
21. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurse's Health Study. Am J Obstet Gynecol 1990;163:285.
22. Lipid Research Clinic Program. Manual of laboratory operations, 2nd ed. Vol 1. Lipid and lipoprotein analysis. Washington, DC: US Government Printing Office, 1974. US Department of Health, Education and Welfare publication NIH 75-628.
23. Friedwald WJ, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:459.
24. Desbuquois B, Ausbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 1971;34:732.
25. Cook NR, Cohen J, Hebert PR, Taylor JO, Henekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995;155:701.
26. Russell-Briefel R, Ezzati T, Pearlman J. Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States 1971-1980. Am J Public Health 1985;75:1173.
27. Nischan P, Ebeling K, Thomas DB, Hirsch U. Comparisons of recalled and validated oral contraceptive histories. Am J Epidemiol 1993;138:697.
28. Coulter A, Vessey M, McPherson K, et al. The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127.
29. Stolley PD, Tonascia JA, Sartwell PE, et al. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol 1978;107:226.
30. Rosenberg MJ, Layde PM, Ory HW, et al. Agreement between women's histories of oral contraceptive use and physician records. Int J Epidemiol 1983;12:84.
31. Glass R, Johnson B, Vessey M. Accuracy of recall of histories of oral contraceptive use. Br J Prev Soc Med 1974;28:273.